Hint mode is switched on Switch off
For swift navigation between sections

Organization: Jubilant Pharma
LEI 254900FD7PRU3PQBQB82

Organization name
Jubilant Pharma Limited
Country name
Singapore
Country of registration
Singapore
Industry
Pharmaceutical Preparation and Biotechnology
Bond debt
-

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Latest data on

Quotes

Request sent
Access denied
Send request
Quotes provided by information providers are indicative in nature

Profile

Jubilant Pharma provides solutions to global pharmaceutical customers, offering a wide range of products & services. We are a Company engaged in development, manufacture and supply of APIs, Solid Dosage Formulations, Radiopharmaceuticals, and Allergy Therapy Products. Our services comprise Contract Manufacturing of Sterile Injectables , Ointments, Creams and Liquids. Jubilant Pharma is a subsidiary of Jubilant Life Sciences, an integrated global pharmaceutical and life sciences company, which has been ranked No. 6 amongst the Top 10 global contract manufacturing & services outsourcing players of the pharmaceutical industry (Source: UNCTAD 2011).

Awards

News

19/08/2022 S&P Global Ratings withdrew Local Currency LT credit rating for Jubilant Pharma
19/08/2022 S&P Global Ratings withdrew Foreign Currency LT credit rating for Jubilant Pharma
25/07/2022 Fitch Ratings withdrew LT Int. Scale (foreign curr.) credit rating for Jubilant Pharma
25/07/2022 Fitch Ratings downgrades LT Int. Scale (foreign curr.) credit rating of Jubilant Pharma to "BB-"; outlook stable
22/07/2022 Fitch Downgrades Jubilant Pharma to 'BB-'/Stable; Withdraws Ratings (Rating action commentary)
All organization news

Documentation

IFRS/US GAAP reports

2019
I q eng
II q eng
III q eng
2018
I q eng
II q eng
III q eng
IV q eng
2017
IV q eng
Show all Hide
Authorization required
You need to request access

Stocks

Latest issues

Show all

Bond debt by currency

Show more Hide

Codes

  • LEI
    254900FD7PRU3PQBQB82
  • SIC
    6719 Holding companies
  • ICB
    4,500 Health Care
  • NAICS
    325,412 Pharmaceutical Preparation Manufacturing

Credit and ESG Ratings

Macroeconomic Indicators - Jubilant Pharma

Registration is required to get access.